A subcutaneous biodegradable implant for sustained delivery of tenofovir alafenamide (TAF) for HIV pre-exposure prophylaxis (PrEP)

Girouard, N., Johnson, L., Luecke, E., Demkovich, Z., Jester, T., Li, A., Johnson, P., & van der Straten, A. (2018). A subcutaneous biodegradable implant for sustained delivery of tenofovir alafenamide (TAF) for HIV pre-exposure prophylaxis (PrEP). AIDS Research and Human Retroviruses, 34, 107.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

OCCASIONAL PAPER

Bringing an equity-centered framework to research
OCCASIONAL PAPER

The Preschool Entitlement
OCCASIONAL PAPER

Culturally informed community engagement
Article

Far-right and Jihadi terrorism within the United States